SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-032133
Filing Date
2011-05-27
Accepted
2011-05-27 16:46:29
Documents
5
Period of Report
2011-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-13149_18k.htm 8-K 143059
2 EX-10.1 a11-13149_1ex10d1.htm EX-10.1 148152
3 EX-10.2 a11-13149_1ex10d2.htm EX-10.2 60973
4 EX-10.3 a11-13149_1ex10d3.htm EX-10.3 55294
5 EX-10.4 a11-13149_1ex10d4.htm EX-10.4 71340
  Complete submission text file 0001104659-11-032133.txt   480206
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 11878802
SIC: 2836 Biological Products, (No Diagnostic Substances)